Corona Health-A Study- and Sensor-Based Mobile App Platform Exploring Aspects of the COVID-19 Pandemic.

digital phenotyping ecological momentary assessment longitudinal studies mobile crowdsensing mobile health

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
10 07 2021
Historique:
received: 07 06 2021
revised: 06 07 2021
accepted: 06 07 2021
entrez: 24 7 2021
pubmed: 25 7 2021
medline: 30 7 2021
Statut: epublish

Résumé

Physical and mental well-being during the COVID-19 pandemic is typically assessed via surveys, which might make it difficult to conduct longitudinal studies and might lead to data suffering from recall bias. Ecological momentary assessment (EMA) driven smartphone apps can help alleviate such issues, allowing for in situ recordings. Implementing such an app is not trivial, necessitates strict regulatory and legal requirements, and requires short development cycles to appropriately react to abrupt changes in the pandemic. Based on an existing app framework, we developed Corona Health, an app that serves as a platform for deploying questionnaire-based studies in combination with recordings of mobile sensors. In this paper, we present the technical details of Corona Health and provide first insights into the collected data. Through collaborative efforts from experts from public health, medicine, psychology, and computer science, we released Corona Health publicly on Google Play and the Apple App Store (in July 2020) in eight languages and attracted 7290 installations so far. Currently, five studies related to physical and mental well-being are deployed and 17,241 questionnaires have been filled out. Corona Health proves to be a viable tool for conducting research related to the COVID-19 pandemic and can serve as a blueprint for future EMA-based studies. The data we collected will substantially improve our knowledge on mental and physical health states, traits and trajectories as well as its risk and protective factors over the course of the COVID-19 pandemic and its diverse prevention measures.

Identifiants

pubmed: 34299846
pii: ijerph18147395
doi: 10.3390/ijerph18147395
pmc: PMC8303497
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : German Federal Ministry of Education and Research
ID : 01KX2021
Organisme : German Research Foundation
ID : 428318753
Organisme : German Federal Ministry of Education and Research
ID : 01EO1501
Organisme : German Research Foundation
ID : HE 4566/5-1

Références

J Psychosom Res. 2020 Sep;136:110186
pubmed: 32682159
Front Psychiatry. 2020 Apr 16;11:333
pubmed: 32372991
N Engl J Med. 2014 Jul 24;371(4):372-9
pubmed: 25054722
Front Neurosci. 2020 Feb 28;14:164
pubmed: 32184708
Curr Opin Psychol. 2020 Dec;36:19-24
pubmed: 32361334
Lancet Psychiatry. 2021 Jul;8(7):610-619
pubmed: 33965057
Int J Environ Res Public Health. 2021 Jun 08;18(12):
pubmed: 34201322
JMIR Mhealth Uhealth. 2019 Oct 30;7(10):e13978
pubmed: 31670692
Int J Environ Res Public Health. 2020 Mar 31;17(7):
pubmed: 32244498
Psychosom Med. 2021 May 1;83(4):328-337
pubmed: 33009276
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
PLoS One. 2020 Dec 31;15(12):e0244809
pubmed: 33382859
Front Neurosci. 2018 Dec 18;12:971
pubmed: 30618590
J Med Internet Res. 2020 Jun 30;22(6):e15547
pubmed: 32602842
J Affect Disord. 2020 Dec 1;277:55-64
pubmed: 32799105
J Med Internet Res. 2018 Jul 20;20(7):e241
pubmed: 30030209
Neuropsychopharmacology. 2021 Jan;46(1):45-54
pubmed: 32679583
Int J Environ Res Public Health. 2020 Jul 02;17(13):
pubmed: 32630821
Nat Biotechnol. 2015 May;33(5):462-3
pubmed: 25965751
JAMA. 2017 Oct 3;318(13):1215-1216
pubmed: 28973224
Nat Neurosci. 2020 Jul;23(7):800-804
pubmed: 32424287
Healthcare (Basel). 2021 Feb 09;9(2):
pubmed: 33572425
Healthc Policy. 2019 Feb;14(3):19-28
pubmed: 31017863
Int J Environ Res Public Health. 2021 Apr 01;18(7):
pubmed: 33916019

Auteurs

Felix Beierle (F)

Institute of Clinical Epidemiology and Biometry, University of Würzburg, 97080 Würzburg, Germany.

Johannes Schobel (J)

DigiHealth Institute, Neu-Ulm University of Applied Sciences, 89231 Neu-Ulm, Germany.

Carsten Vogel (C)

Institute of Clinical Epidemiology and Biometry, University of Würzburg, 97080 Würzburg, Germany.

Johannes Allgaier (J)

Institute of Clinical Epidemiology and Biometry, University of Würzburg, 97080 Würzburg, Germany.

Lena Mulansky (L)

Institute of Clinical Epidemiology and Biometry, University of Würzburg, 97080 Würzburg, Germany.

Fabian Haug (F)

Institute of Databases and Information Systems, Ulm University, 89081 Ulm, Germany.

Julian Haug (J)

Institute of Clinical Epidemiology and Biometry, University of Würzburg, 97080 Würzburg, Germany.

Winfried Schlee (W)

Department of Psychiatry and Psychotherapy, University Regensburg, 93053 Regensburg, Germany.

Marc Holfelder (M)

LA2 GmbH, 91054 Erlangen, Germany.

Michael Stach (M)

Institute of Databases and Information Systems, Ulm University, 89081 Ulm, Germany.

Marc Schickler (M)

Institute of Databases and Information Systems, Ulm University, 89081 Ulm, Germany.

Harald Baumeister (H)

Department of Clinical Psychology and Psychotherapy, Ulm University, 89081 Ulm, Germany.

Caroline Cohrdes (C)

Mental Health Research Unit, Department of Epidemiology and Health Monitoring, Robert Koch Institute, 12101 Berlin, Germany.

Jürgen Deckert (J)

Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital Würzburg, 97080 Würzburg, Germany.

Lorenz Deserno (L)

Department of Child and Adolescent Psychiatry, University Hospital Würzburg, 97080 Würzburg, Germany.

Johanna-Sophie Edler (JS)

Mental Health Research Unit, Department of Epidemiology and Health Monitoring, Robert Koch Institute, 12101 Berlin, Germany.

Felizitas A Eichner (FA)

Institute of Clinical Epidemiology and Biometry, University of Würzburg, 97080 Würzburg, Germany.

Helmut Greger (H)

Service Center Medical Informatics, University Hospital Würzburg, 97080 Würzburg, Germany.

Grit Hein (G)

Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital Würzburg, 97080 Würzburg, Germany.

Peter Heuschmann (P)

Institute of Clinical Epidemiology and Biometry, University of Würzburg, 97080 Würzburg, Germany.

Dennis John (D)

Lutheran University of Applied Sciences Nürnberg, 90429 Nürnberg, Germany.

Hans A Kestler (HA)

Institute of Medical Systems Biology, Ulm University, 89081 Ulm, Germany.

Dagmar Krefting (D)

Department of Medical Informatics, University Medical Center Göttingen, 37075 Göttingen, Germany.

Berthold Langguth (B)

Department of Psychiatry and Psychotherapy, University Regensburg, 93053 Regensburg, Germany.

Patrick Meybohm (P)

Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Würzburg, 97080 Würzburg, Germany.

Thomas Probst (T)

Department for Psychotherapy and Biopsychosocial Health, Danube University Krems, 3500 Krems, Austria.

Manfred Reichert (M)

Institute of Databases and Information Systems, Ulm University, 89081 Ulm, Germany.

Marcel Romanos (M)

Department of Child and Adolescent Psychiatry, University Hospital Würzburg, 97080 Würzburg, Germany.

Stefan Störk (S)

Comprehensive Heart Failure Center, University and University Hospital Würzburg, 97080 Würzburg, Germany.
Department of Internal Medicine I, University Hospital Würzburg, 97080 Würzburg, Germany.

Yannik Terhorst (Y)

Department of Clinical Psychology and Psychotherapy, Ulm University, 89081 Ulm, Germany.

Martin Weiß (M)

Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital Würzburg, 97080 Würzburg, Germany.

Rüdiger Pryss (R)

Institute of Clinical Epidemiology and Biometry, University of Würzburg, 97080 Würzburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH